SGMO - Sangamo Therapeutics - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

SGMO is currently covered by 7 analysts with an average potential upside of $5.58 (92.49%) from yesterday's end of day stock price of $0.49. Sangamo Therapeutics activity chart has currently 9 price targets and 30 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 225 days.

Highest price target for SGMO is $7, Lowest price target is $7, average price target is $7.

Most recent stock forecast was given by NICOLE GERMINO from TRUIST on 07-Nov-2023. First documented stock forecast 18-May-2015.

Currently, out of the existing stock ratings of SGMO - 12 which are a Buy (66.67%), 6 which are a Hold (33.33%)

Analyst name


Current price target

Potential distance

Previous price target


Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score


1 months 2 days ago

0/1 (0%)

$11.48 (109.13%)



$0.51 (104.08%)

1 months 3 days ago

1/3 (33.33%)

$6.32 (92.30%)




$1.51 (308.16%)

1 months 6 days ago

0/2 (0%)

$5.96 (211.98%)



3 months 28 days ago

1/2 (50%)

$1.38 (43.79%)




3 months 29 days ago

1/1 (100%)

$0.26 (6.28%)


Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SGMO (Sangamo Therapeutics) average time for price targets to be met?

On average it took 225 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on SGMO (Sangamo Therapeutics) with a proven track record?


Which analyst has the most public recommendations on SGMO (Sangamo Therapeutics)?

Gena Wang works at BARCLAYS and has 3 price targets and 3 ratings on SGMO

Which analyst is the currently most bullish on SGMO (Sangamo Therapeutics)?

Liana Moussatos with highest potential upside - $11.51

Which analyst is the currently most reserved on SGMO (Sangamo Therapeutics)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart